Part Number
Part Number:
NSN:
NIIN:
Item Name:
POTASSIUM CHLORIDE INJECTION , USP
Definition:
INC 09395 CANCELLED/REPLACED BY ,INC 48876, FIIG A45100, APP-KEY A , ON 122396.
CAGE Information
| Code | Company |
|---|---|
| 60567 | LYPHOMED INC DIV OF FUJISAWA USA INC |
Federal Supply Class
Title
DRUGS AND BIOLOGICALS
Inclusions:
INCLUDES ALL DRUGS, MEDICINAL GRADE CHEMICALS, AND BIOLOGICALS SUBJECT TO THE FEDERAL FOOD, DRUG AND COSMETIC ACT, LISTED IN THE MONOGRAPH SECTION OF THE U.S. PHARMACOPEIA OR THE NATIONAL FORMULARY OR COVERED BY THE UNITED STATES ADOPTED NAMES (USAN). OTHER NATIONS MAY APPLY THEIR OWN LEGAL DOCUMENTS.
Exclusions:
EXCLUDES MEDICATED COSMETICS AND TOILETRIES CLASSIFIABLE IN FSC 6508 AND IN VITRO DIAGNOSTIC SUBSTANCES AND REAGENTS CLASSIFIABLE IN FSC 6550, AND VETERINARY DRUGS AND BIOLOGICALS CLASSIFIABLE IN FSC 6509.
Characteristics (Decoded)
| MRC | Requirements Statement | Clear Text Reply |
|---|---|---|
| CBBL | FEATURES PROVIDED | STERILE |
| THPE | THERAPEUTIC EQUIVALENT | ANY A RATED DRUG |
| CQCT | PRIMARY CONTAINER TYPE | VIAL |
| AKJQ | PHARMACEUTICAL VEHICLE TYPE | AQUEOUS |
| CRYD | EXPIRATION DATING PERIOD IN MONTHS | 24 |
| FEAT | SPECIAL FEATURES | MULTIPLE DOSE VIAL; PH ADJUSTED WITH HYDROCHLORIC ACID IF NECESSARY |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 25 |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 30.000 MILLILITERS |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 60.000 MILLIEQUIVALENTS POTASSIUM CHLORIDE ACTIVE INGREDIENT |
| PKTY | UNIT PACKAGE TYPE | BOX |
| CSGS | ADMINISTRATION | INTRAVENOUS |
| CRBW | STABILIZER | PRESERVATIVE AGENT |
| CQPQ | WARNING AND CAUTION STATEMENTS | WARNING: MUST BE DILUTED PRIOR TOADMINISTRATION |